NCT04829149View on ClinicalTrials.gov

Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

CompletedOBSERVATIONAL
Enrollment

5,717

Participants

Timeline

Start Date

June 14, 2016

Primary Completion Date

June 1, 2019

Study Completion Date

August 29, 2019

Conditions
Dyslipidemias
Interventions
OTHER

Observational

Statin therapy group and Rosuzet tablet group

Trial Locations (1)

05545

Hanmi Pharmaceutical Company Limited, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY